NextGen

Tvardi’s next-generation STAT3 inhibitor TTI-109 confirmed rapid prodrug conversion, dose-proportional exposure, and improved tolerability versus TTI-101 in Phase 1 testing. Investorideas.com (www.investorideas.com) a trusted platform for investing ideas, including biotech…

Kevin Dietsch/Getty Images News Nvidia (NASDAQ:NVDA) CEO Jensen Huang announced a wave of new technologies and partnerships at the Computex 2025 conference in Taiwan to reinforce the company’s dominance in…

Key Takeaways: A new Web3 accelerator program has been launched in the UK, backed by Fabric Ventures, Animoca Brands, Coinbase, and Founders Factory. The initiative is aimed at early-stage blockchain…